524 related articles for article (PubMed ID: 30383455)
1. Intravitreal Delivery of VEGF-A
Mezu-Ndubuisi OJ; Wang Y; Schoephoerster J; Falero-Perez J; Zaitoun IS; Sheibani N; Gong S
Curr Eye Res; 2019 Mar; 44(3):275-286. PubMed ID: 30383455
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of rapamycin on the retinal vascular bed during the vaso-obliteration phase in mouse oxygen-induced retinopathy model.
Zhang J; Zhu M; Ruan L; Jiang C; Yang Q; Chang Q; Huang X
FASEB J; 2020 Dec; 34(12):15822-15836. PubMed ID: 33103304
[TBL] [Abstract][Full Text] [Related]
3. Sildenafil attenuates vaso-obliteration and neovascularization in a mouse model of retinopathy of prematurity.
Fawzi AA; Chou JC; Kim GA; Rollins SD; Taylor JM; Farrow KN
Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1493-501. PubMed ID: 24519428
[TBL] [Abstract][Full Text] [Related]
4. Geldanamycin treatment reduces neovascularization in a mouse model of retinopathy of prematurity.
Kociok N; Krohne TU; Poulaki V; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):258-66. PubMed ID: 16741710
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of CCN1-enhanced retinal neovascularization in oxygen-induced retinopathy through PI3K/Akt-VEGF signaling pathway.
Di Y; Zhang Y; Yang H; Wang A; Chen X
Drug Des Devel Ther; 2015; 9():2463-73. PubMed ID: 25995618
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous assessment of aberrant retinal vascularization, thickness, and function in an in vivo mouse oxygen-induced retinopathy model.
Mezu-Ndubuisi OJ; Adams T; Taylor LK; Nwaba A; Eickhoff J
Eye (Lond); 2019 Mar; 33(3):363-373. PubMed ID: 30209267
[TBL] [Abstract][Full Text] [Related]
7. Role of the adrenergic system in a mouse model of oxygen-induced retinopathy: antiangiogenic effects of beta-adrenoreceptor blockade.
Ristori C; Filippi L; Dal Monte M; Martini D; Cammalleri M; Fortunato P; la Marca G; Fiorini P; Bagnoli P
Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):155-70. PubMed ID: 20739470
[TBL] [Abstract][Full Text] [Related]
8. Suppression of Retinal Neovascularization by Anti-CCR3 Treatment in an Oxygen-Induced Retinopathy Model in Mice.
Hirahara S; Nozaki M; Ohbayashi M; Hasegawa N; Ozone D; Ogura Y
Ophthalmic Res; 2017; 58(1):56-66. PubMed ID: 28376500
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling.
Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH
Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515
[TBL] [Abstract][Full Text] [Related]
10. Effect of brimonidine on retinal and choroidal neovascularization in a mouse model of retinopathy of prematurity and laser-treated rats.
Kusari J; Padillo E; Zhou SX; Bai Y; Wang J; Song Z; Zhu M; Le YZ; Gil DW
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5424-31. PubMed ID: 21482645
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of VEGF by retinoic acid during hyperoxia prevents retinal neovascularization and retinopathy.
Wang L; Shi P; Xu Z; Li J; Xie Y; Mitton K; Drenser K; Yan Q
Invest Ophthalmol Vis Sci; 2014 May; 55(7):4276-87. PubMed ID: 24867581
[TBL] [Abstract][Full Text] [Related]
12. Regulation of vascular endothelial growth factor by oxygen in a model of retinopathy of prematurity.
Pierce EA; Foley ED; Smith LE
Arch Ophthalmol; 1996 Oct; 114(10):1219-28. PubMed ID: 8859081
[TBL] [Abstract][Full Text] [Related]
13. In vivo retinal vascular oxygen tension imaging and fluorescein angiography in the mouse model of oxygen-induced retinopathy.
Mezu-Ndubuisi OJ; Teng PY; Wanek J; Blair NP; Chau FY; Reddy NM; Raj JU; Reddy SP; Shahidi M
Invest Ophthalmol Vis Sci; 2013 Oct; 54(10):6968-72. PubMed ID: 24052641
[TBL] [Abstract][Full Text] [Related]
14. Triamcinolone reduces neovascularization, capillary density and IGF-1 receptor phosphorylation in a model of oxygen-induced retinopathy.
Hartnett ME; Martiniuk DJ; Saito Y; Geisen P; Peterson LJ; McColm JR
Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4975-82. PubMed ID: 17065516
[TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenic effect of metformin in mouse oxygen-induced retinopathy is mediated by reducing levels of the vascular endothelial growth factor receptor Flk-1.
Joe SG; Yoon YH; Choi JA; Koh JY
PLoS One; 2015; 10(3):e0119708. PubMed ID: 25785990
[TBL] [Abstract][Full Text] [Related]
16. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.
Banin E; Dorrell MI; Aguilar E; Ritter MR; Aderman CM; Smith AC; Friedlander J; Friedlander M
Invest Ophthalmol Vis Sci; 2006 May; 47(5):2125-34. PubMed ID: 16639024
[TBL] [Abstract][Full Text] [Related]
17. Epithelial Membrane Protein 2 (EMP2) Promotes VEGF-Induced Pathological Neovascularization in Murine Oxygen-Induced Retinopathy.
Sun M; Wadehra M; Casero D; Lin MC; Aguirre B; Parikh S; Matynia A; Gordon L; Chu A
Invest Ophthalmol Vis Sci; 2020 Feb; 61(2):3. PubMed ID: 32031575
[TBL] [Abstract][Full Text] [Related]
18. Avastin treatment reduces retinal neovascularization in a mouse model of retinopathy of prematurity.
Rabinowitz R; Priel A; Rosner M; Pri-Chen S; Spierer A
Curr Eye Res; 2012 Jul; 37(7):624-9. PubMed ID: 22578253
[TBL] [Abstract][Full Text] [Related]
19. Antiangiogenesis effects of endostatin in retinal neovascularization.
Bai YJ; Huang LZ; Zhou AY; Zhao M; Yu WZ; Li XX
J Ocul Pharmacol Ther; 2013 Sep; 29(7):619-26. PubMed ID: 23545016
[TBL] [Abstract][Full Text] [Related]
20. Effects of somatostatin analogues on retinal angiogenesis in a mouse model of oxygen-induced retinopathy: involvement of the somatostatin receptor subtype 2.
Dal Monte M; Ristori C; Cammalleri M; Bagnoli P
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3596-606. PubMed ID: 19324858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
